What You Should Know:
- Israeli-based G Medical Innovation has withdrawn its plans for an initial public offering (IPO) on Tuesday, Nasdaq first reports.
- The company originally filed
an IPO to raise $30 million by offering 5 million shares at a price range of $5
to $7 last month to list on the Nasdaq under the symbol GMVD.
- The recent withdrawal marks the company's second
attempt to go public in the US, previously filing in May 2019 and withdrawing
the following August. The company
Read More
AmWell IPO and Google Deal – Five Key Takeaways to Know
1) COVID-19 Has Driven Revenue Up 77%
The headline revenue data (summarised below) provides very positive news for AmWell and its new investor, Google. Notably:
- Even prior to COVID-19, the company was growing well with revenues increasing by 31% in 2019 compared to 2018.
- This rate of growth has accelerated in 1H20, with overall revenue up 77% in the same period in 2019.
- The 2019 growth was partly driven by a small increase in the number of health plan subscription customers and
Read More
Analysis: August Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020.
M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical
What You Should Know:
- Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020.
- Deal expected to close in 1H 2021.
- Varian Medical will maintain its brand name and operate “independently”
- Siemens AG will drop holding in Siemens Healthineers from 85% to 72% as part of the transaction.
News of the deal between Siemens Healthineers and Varian Medical will have caught many industry onlookers off guard on Sunday evening.
Read More
Analysis: July Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020.
While a pandemic ravages the country, technology valuations are soaring. The Nasdaq hit an all-time high during the month of July, sailing through the 10,000 mark to post YTD gains of nearly 20%, representing a 56% increase off the low water mark on March 23. More notably, the Nasdaq has
Read More
HGP Semi-Annual Health IT Market Review: 6 Key Trends to Know
Healthcare Growth Partners, an
Investment Banking and Strategic Advisory firm exclusively focused on the
transformational health
IT market, today announced the release of its Semi-Annual Health IT Market
Review report that summarizes M&A and private equity activity across health
IT, health information services, and digital health.
Report Background/Methodology
This edition of the report includes feedback from our survey
of private equity professionals and their response to
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Dr. Ulrik Kristensen, Senior Market Analyst at Signify Research
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is
Read More
Analysis: Why Digital Health Investors are Falling in Love with Femtech
Women’s health technology, known as Femtech, is one of the fastest-growing and well-funded categories of digital health. Femtech generally encompasses a range of digital health software and tech-enabled service providers that cater to the specific biological needs of women. These needs span from general health and wellness to reproductive health, including fertility, pregnancy, and nursing care.
Today, reproductive health is the focal point of femtech, thanks in part to the
Read More
Analysis: January Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of January 2020.
Ten years into the bull market, we operate in a heightened state of awareness for any indication of market weakness that may signal a downturn. While debt levels are rising and GDP growth somewhat sluggish, the world of private equity, public equity, and M&A continues to be in full swing bull
Read More
2020 Semi-Annual Health IT Market Review: 5 Key Indicators to Watch
- Healthcare Growth Partners (HGP) releases its Semi-Annual Health IT Market Review report that summarizes M&A and private equity activity across health IT, digital health, etc.
- The report reveals health IT as a healthy sector going into 2020 and outlines key 2019 trends and 2020 indicators to watch in the market this year.
Healthcare Growth Partners, an investment bank and strategic advisory firm for health IT has announced the release of its annual Semi-Annual Health IT
Read More
